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Effects of percutaneous transluminal
angioplasty on muscle BOLD-MRI in patients
with peripheral arterial occlusive disease:
preliminary results
Abstract The purpose was to evaluate
the effect of percutaneous transluminal
angioplasty (PTA) of the superficial
femoral artery (SFA) on the blood
oxygenation level-dependent (BOLD)
signal change in the calf musculature of
patients with intermittent claudication.
Ten patients (mean age, 63.4±
11.6 years) with symptomatic periph-
eral arterial occlusive disease (PAOD)
caused by SFA stenoses were investi-
gated before and after PTA. Patients
underwent BOLD-MRI 1 day before
and 6weeks after PTA.AT2*-weighted
single-shot multi-echo echo-planar
MR-imaging technique was applied.
The BOLD measurements were ac-
quired at mid-calf level during reactive
hyperaemia at 1.5 T. This transient
hyperperfusion of themuscle tissuewas
provoked by suprasystolic cuff com-
pression. Key parameters describing
the BOLD signal curve included max-
imum T2* (T2*max), time-to-peak to
reach T2*max (TTP) and T2* end value
(EV) after 600 s of hyperemia. Paired t-
tests were applied for statistic compar-
ison. Between baseline and post-PTA,
T2*max increased from 11.1±3.6% to
12.3±3.8% (p=0.51), TTP decreased
from 48.5±20.8 s to 35.3±11.6 s (p=
0.11) and EV decreased from 6.1±
6.4% to 5.0±4.2% (p=0.69). In con-
clusion, BOLD-MRI reveals changes
of the key parameters T2*max, TTP, and
EVafter successful PTA of the calf
muscles during reactive hyperaemia.
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Introduction
Arteriosclerosis is a slow progressive disease that causes
accumulation of fatty substances, cholesterol, calcium, and
fibrin forming plaque within the inner wall of the arteries
[1, 2]. Additionally, changes of the muscle tissue fiber type
composition and architecture of microvasculature contri-
buting to the impairment of blood supply were described
[3–5]. The disease may be undiscovered as long as the
blood supply is compensated by collateral pathways. A
restriction in local perfusion can lead to symptoms like
intermittent claudication up to gangrene of the extremities.
Depending on the clinical stage, a conservative treatment
approach or revascularization may be indicated. The revas-
cularization strategies involve percutaneous transluminal
angioplasty (PTA) and open surgery. Presently, PTA is an
established minimally invasive technique to treat vessel
stenoses and/or occlusions by balloon dilation or stenting. Its
beneficial effect on the macrocirculation is generally
accepted and can be measured clinically by several methods
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including ankle-brachial index (ABI) or oscillography [6]. A
drawback of these methods is their limited diagnostic value
in case of incompressible calcified arteries [7].
Blood oxygenation level-dependent (BOLD) magnetic
resonance imaging (MRI) of the human skeletal muscle
was recently introduced as a new technique to describe the
perfusion state of the lower limb musculature [8–11].
However, the mechanism of the muscle BOLD signal is not
yet fully understood, but it is believed that the ratio of
oxygenated to deoxygenated blood in the muscle tissue
seems to play a major role for the BOLD response. It is also
assumed that the mechanism is rather similar to that of the
BOLD effect in the human brain [10, 11], where the brain
regional hyperperfusion leads to an overproportional
increase of oxyhemoglobin, which is accompanied by an
increase of the BOLD signal [12–14].
Muscle BOLD is also dependent on muscle blood
volume, perfusion vascular architecture and magnetic field
angulation [15–17], but it seems to be more complex
compared with the BOLD response in the brain.
First investigations of muscle BOLD MRI in peripheral
arterial occlusive disease (PAOD) patients revealed signif-
icant changes of the muscle T2* BOLD time at calf level
compared with a healthy age-matched control group [18].
These changes were referred to as an impairment of blood
inflow and decrease in perfusion reserve capacity. The
alterations of muscle tissue composition and microvascular
architecture were also proposed as influencing factors.
Therefore, a detectable BOLD signal change can be
expected after endovascular therapy.
The purpose of our study was to compare the muscle
BOLD response during reactive hyperemia in a calf muscle
in patients suffering from intermittent claudication before
and 6 weeks after PTA of the superficial femoral artery
(SFA). A cuff-compression paradigm was applied.
Materials and methods
During an 8-month study period in 2006–2007, ten patients
(63.4±11.6 years, eight male, two female) with intermittent
claudication underwent antegrade PTA of the SFA. BOLD
measurements in the gastrocnemius muscle of the calf were
performed one day before and 6 weeks after PTA.
All PAOD-patients suffered from intermittent claudica-
tion with restriction of pain-free walking distance <200 m
and an ABI at rest of <1. Diagnostic pre-evaluation of the
SFA was performed by duplex sonography (ATL HDI
5000; Philips, Best, The Netherlands). Only patients with
up to two hemodynamic relevant SFA stenoses >50% and a
two- or three-vessel runoff of the infrapopliteal arteries
were included in this study. Exclusion criteria were all
common contraindications to MRI, like pacemakers,
ferromagnetic implants and claustrophobia.
The study population’s baseline characteristics are
summarized in Table 1.
The study was approved by the local ethic committee
and informed consent was obtained from every patient
before entering the study.
Cuff-compression paradigm for reactive hyperemia
Reactive hyperemia was provoked using a cuff-compression
paradigm [18, 19]. The cuff (15×75 cm) of a conventional
leg-sphygmomanometer was fixed at mid-thigh level. Cuff
compression with a pressure of 50 mmHg above the
individual brachial systolic blood pressure was applied during
the ischemic phase for 240 s. Cuff compression was
performed manually and was adapted within 5 s. BOLD-
MRI measurements started contemporaneously with cuff
deflation and continued for 600 s. Cuff deflation was initiated
by fast opening of the air valve.
Digital subtraction angiography (DSA)-guided
antegrade PTA
The patients were referred to the interventional unit of our
radiological department for balloon angioplasty. The
examinations were performed by two experienced inter-
ventional radiologists on a standard angiography unit
(Multistar; Siemens Medical Systems, Erlangen, Ger-
many). In the DSA unit, percutaneous vascular access
was achieved by an antegrade puncture of the common
femoral artery and a 4-F introducer sheath (Terumo
Radifocus introducer II; Interleuvenlaan, Leuven, Bel-
gium) was placed within the femoral artery.
To visualize the entire infrainguinal arteries including
the SFA, deep femoral artery, popliteal artery, peroneal
artery, anterior and posterior tibial artery diagnostic DSA
with intraarterial injection of Ultravist 300 (Schering,
Berlin, Germany) was acquired in four steps.
In all patients, a guidewire (V-18 control wire; Boston
Scientific Medi-Tech, La Garenne Colombes Cedex,
France) passage through the stenotic lesion was feasible.
Table 1 Summary of clinical data
Patients (n=10)
Risk factors
Smoking history 8 (80%)
Respiratory disease 4 (25%)
Arterial hypertension 7 (70%)
Hyperlipidemia 8 (80%)
Diabetes mellitus 2 (20%)
Medication
Lipid-lowering agent 7 (70%)
Blood-pressure drug 8 (80%)
Heparin/vitamin K antagonist 1 (10%)
Aspirin/clopidogrel 10 (100%)
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The lesions were treated by balloon angioplasty (Sub-
marine Plus; Invatec Innovative Technologies, Roncadelle,
Italy).
Balloon diameter varied between 4 and 5 mm and length
ranged from 2 to 4 cm. The results of angioplasty were
documented by post-interventional DSA, which was also
used to exclude thrombembolic complications below the
knee. The puncture site was closed with a StarClose device
(Abbott Vascular Devices, Abbott Laboratories, Redwood
City, Calif.).
MR-setup and BOLD measurements
All MRI measurements were performed on a 1.5-T scanner
(Sonata; Siemens Medical Solution, Erlangen, Germany).
For signal detection a dedicated peripheral vascular array
coil was used. Patients were investigated in the supine
position.
A fat-saturated single-shot multi-echo echo-planar im-
aging (EPI) sequence with a temporal resolution of one
acquisition per second was applied for muscle BOLD
measurements. Four axial slices with a slice thickness of
5 mm and an imaging gap of 2.5 mm were positioned in the
upper calf at maximal diameter. Acquisition parameters
were as follows: 380×238 mm field of view; 128×80
matrix size; 1,000 ms repetition time; four echo-images
with effective echo times (TEeff) of 16, 38, 61, 83 ms. EPI
images were referenced to anatomical T1-weighted spin-
echo images.
Data analysis
Oxygenation (T2*) and initial signal intensity (I0) effects
were separated by a pixel-by-pixel least-square fit of
monoexponential decay to the signal intensities of the
echo-images using a postprocessing software implemented
on our MR scanner. Parameter maps of T2* were generated









where I0 refers to the initial signal intensity, which is
modulated by perfusion, proton density, and T1 [20].
Based on the T2*-maps, a region-of-interest (ROI)
analysis was performed using the statistical parametric
mapping software BrainVoyager (Brain Innovation, Maas-
tricht, Netherlands).
AT2* time-course was extracted from a rectangular ROI
with ~100 pixels within the gastrocnemius muscle. Pixels
containing larger arteries and veins were excluded.
Data analysis was performed using self-developed
Matlab (Mathworks, Natick, Mass., USA) routines. The
data was averaged over the four acquired slices and
normalized with respect to the average T2* value during
the first three seconds of the measurement, i.e., after cuff
deflation. Three key parameters were determined: maxi-
mum T2* (T2*max), time to peak (TTP), i.e., the elapsed
time between cuff deflation and T2*max, and the T2* end
value (EV)—the mean T2* of the last 2 s of the entire
measurement lasting 600 s relative to the baseline. These
muscle BOLD parameters were calculated for each of the
patients before and 6 weeks after PTA. Paired t-tests were
performed to compare pre- and post PTA key parameters
T2*max, TTP and EV and for the ABI values before and
after interventions. A p value <0.05 was considered as
significant. No adjustments of p values for multiple
comparisons were done. Statistical analyses were carried
out with SPSS (ver. 15).
Results
The i.a. DSA with PTA and the muscle BOLD procedure
were well tolerated by all patients. DSA images acquired
after PTA demonstrated a patent SFA or a stenosis grade
<25%. In seven patients, a three-vessel run-off and in three
patients a two-vessel run-off below the knee was observed.
No thrombembolic complications occurred and the infra-
popliteal run-off remained unchanged.
The ABI before PTA—averaged over all patients—was
0.74±0.10 at rest and 0.51±0.14 after exercise (p=0.001).
Six weeks after the intervention the mean ABI increased to
0.92±0.14 at rest and 0.77±0.22 after exercise (p=0.002).
The ABI improved on average by >0.15, reflecting the
therapeutic success of the PTA treatment (Table 2). One
patient was excluded due to incompressibility of calcified
arteries and false high values in ABI measurements.
Muscle BOLD response during reactive hyperemia
Figure 1 illustrates the mean normalized T2* time-course
in the gastrocnemius muscle of PAOD patients (n=10)
during 600 s of post-occlusive reactive hyperemia before
(gray) and after PTA (black). Comparing the T2* time-
courses, differences of the key parameters were detected.
Firstly, an acceleration of BOLD peaking was observed in
the post-PTA group, which is reflected by a decline of TTP
from 48.5 s±20.8 s to 35.3 s±11.6 s (p=0.11). Secondly,
the T2*max amplitude increased from 11.1%±3.6% to
12.3%±3.8% (p=0.51) after treatment. And finally, the
post-interventional muscle BOLD response showed a
larger decrease after peaking, leading to a smaller EV of
5.0 s±4.2 s compared with 6.1 s±6.4 s (p=0.69). The
BOLD data are presented in Table 2.
Figure 2a demonstrates the results of PTA and BOLD
response of an 80-year-old patient. At the top, pre- and
post-interventional DSAs of the right SFA are demonstra-
ted. The short distance stenosis of the SFA was dilated
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using a 5/40-mm balloon catheter. A small not flow
hampering dissection within the region of angioplasty was
observed; however, the remaining stenosis was <25%. The
corresponding T2* time-courses of the muscle BOLD
signal pre- and post-PTA are shown at the bottom. Both
time-courses show a steep increase in T2* after cuff
deflation. This is followed by a slow decline after peaking
at TTP until the T2* value almost remains constant. The
T2* time-course after PTA displays a slightly accelerated
TTP with an earlier peaking compared to the T2* time-
course before PTA. In addition, the post-interventional
BOLD response shows an increase of T2*max. The ABI of
this patient revealed a substantial increase from 0.60 to
0.88 after PTA at rest. Another PAOD patient is demon-
strated in Fig. 2b after PTA of a stenotic tandem lesion in
the SFA. The BOLD curve demonstrates clearly an
acceleration of T2* peaking.
Discussion
The BOLD effect in the skeletal muscle is still an
underinvestigated field of research. Furthermore, the
muscle BOLD effect is presently not fully understood but
it is believed that the muscle BOLD signal reflects—at
least partially—the perfusion state of the muscle tissue [9–
11, 16, 17].
The muscle BOLD response during reactive hyperemia
has been described recently in PAOD patients suffering
from intermittent claudication symptoms [18]. A delay in
BOLD peaking (TTP) during reactive hyperemia was
described. Additionally, a reduction of the T2*max was
observed and the BOLD signal recovery (EV) was signi-
ficantly delayed. It was assumed that the impairment of
blood inflow due to atherosclerotic lesions was predomi-
nantly responsible for these effects [18].
So far, the influence of an underlying vascular disease and
its impact on the muscle BOLD response after revascular-
ization PTA-treatment has not yet been elucidated. In our
study, we investigated symptomatic PAOD patients suffering
from intermittent claudication with BOLDMRI before and 6
weeks after PTA treatment. In general, it is well accepted that
stenosis treatment improves the macro- and microcirculation
of the dependent tissue. Therefore, post-interventional
changes of muscle BOLD response are expected. To go
one step further, we hypothesized that the PTA treatment
might reverse the PAOD-induced changes back to a
normalization of TTP acceleration, increase in T2*max and
BOLD recovery (EV) acceleration.
Blood inflow toward the calf tissue is certainly
optimized by PTA. The blood flow through the original
superficial femoral artery is faster than through the
collaterals. A post-interventional decrease of TTP values
can therefore be expected and was confirmed in this study.
The acceleration was in the time range of ~12 s (p=0.11).
However, this finding was not significant, but demonstrates
hemodynamic changes.
The elimination of stenotic lesions does also explain—at
least partially—the increase of maximal ∆T2* after inter-
vention and might be explained by the optimization of
blood oxygen supply after PTA treatment. This effect was
recently demonstrated by transcutaneous oxygen pressure
measurements (TcPo2), where an improvement of tissue
oxygenation is associated with an increase of oxyhemo-
globin concentration in the capillary bed [21, 22]. It shifts
the Hbox/deox ratio toward higher concentration. This
increases the diamagnetic properties of the blood and
raises the ∆T2* signal. This is also supported by a muscle
BOLD study in healthy volunteers, where good correla-
Table 2 Summary of BOLD-MRI data
Pre-PTA Post-PTA p value
n=10 T2*max (%) 11.1±3.6 12.3±3.8 >0.05
TTP (s) 48.5±20.8 35.3±11.6 >0.05
EV (%) 6.1±6.4 5.0±4.2 >0.05
n=9a ABI at rest 0.74±0.10 0.92±0.14 <0.05
ABI after exercise 0.51±0.14 0.77±0.22 <0.05
aDue to the incompressibility of the arteries, the ABI-values of one patient were not available
Fig. 1 Mean normalized muscle BOLD response before (gray) and
after (black) successful PTA of the SFA obtained from ten patients
suffering from claudication symptoms. In general, the post-
interventional T2* time-course reveals a higher T2*max, a shorter
TTP, and a lower EV than the pre-interventional time-course. The
differences of the key parameters were not significant (p>0.05)
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tion was observed between BOLD response and TcPo2
measurements [19].
Preexisting vasomotor relaxation is observed in PAOD
patients, lowering the flow resistance along the peripheral
arterial tree. BOLD signal changes are also dependent from
blood volume [23]. Therefore, a regain of vasodilatation
properties can also contribute to an increase of BOLD
amplitude (∆T2*max) leading to a higher blood inflow
during reactive hyperemia after intervention. In the light
of these physiological changes, a change of 11.1%±3.6%
to 12.3%±3.8% is rather low and non-significant but
detectable.
Fig. 2 a Top: An 80-year-old patient suffering from claudication
intermittens. Diagnostic DSA pre- and post-PTA. A high-grade
stenosis in the distal part of the SFA was successfully treated by
antegrade PTA using a 5/40 balloon catheter. Bottom: Muscle
BOLD response pre- (gray) and post-PTA (black). During reactive
hyperemia, an accelerated T2* increase with earlier peaking and an
enlarged maximum is observed for the post-interventional T2* time-
course. b Top: A 76-year-old patient suffering from claudication.
Diagnostic DSA pre- and post-PTA. A high-grade tandem stenosis
in the mid and distal part of the left SFAwas successfully treated by
antegrade PTA using a 5/40 balloon catheter. The post-interventional
angiogram displays a non-significant residual stenosis of <30%. A
clear reduction of the collateral pathway was observed. Bottom:
Muscle BOLD response pre- (gray) and post-PTA (black). An
accelerated TTP and an increase of T2* was observed for the post-
interventional T2* time-course
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The optimization of blood inflow also leads to an
accelerated washout of the oxygenated blood from the calf
muscle. Consequently, an acceleration of BOLD signal
recovery to near baseline values can also be expected and is
principally reflected by the lower EV levels in the PTA-
treated group.
Compared with ABI values, changes of the BOLD key
parameters are statistically not significant. This finding
might be explained by the multifactorial influence of the
BOLD response that is not only influenced by the
macrovasculature but also from the microvascular network
architecture, muscle fiber content and vessel angulation in
the static field. We assume that these histological
alterations do not change within 6 weeks after PTA
treatment and might cover the perfusion-dependent BOLD
response [4, 5, 10, 15, 24, 25].
The BOLD measurements are based on a post-occlusive
reactive hyperemia paradigm using cuff-compression atmid-
thigh level. The cuff-compression interrupts arterial inflow
and venous outflow completely. Due to the fast cuff inflation
within 5 s, the contribution of venous filling to the BOLD
effect was, therefore, kept as low as possible [26]. The
application of the cuff-compression technique might be
superior to treadmill paradigms, since it can be standardized
and is independent on the patient’s compliance [27].
There are some limitations of our study. First, the
number of patients included is rather small. However, as a
pilot study our major intent was to demonstrate an effect of
PTA on muscle BOLD response by successful treatment.
However, a trend was observed that underlines an
optimization of blood inflow. A refinement of the
measurement might be mandatory to increase the sensitiv-
ity of the method.
Secondarily, the patient collective is rather heterogene-
ous. Our inclusion criteria were based on claudication
symptoms with high-grade stenosis of the SFA. However,
we did not further differentiate between factors like
number of non-significant stenoses along the arterial axis,
number of crural arteries, blood pressure, venous and
heart insufficiency. Furthermore, some patient were under
antihypertensive drug treatment where a pharmacological
influence on the arterial vessel wall and therefore on the
BOLD signal change can be expected. Patients with
critical limb ischemia (Fontaine Stage III) or demarcation
of necroses (Fontaine Stage IV) were also excluded in this
study because of the risk of progression of tissue loss due
to the absolute ischemia caused by suprasystolic cuff
compression.
It is presently unclear if optimization of MR parameters
or pulse sequence might increase the sensitivity of this
BOLD technique. A change from 1.5 T to higher static
magnetic field strength is presumably another technical
option to increase the sensitivity of muscle BOLD changes.
This technical approach is presently under investigation
[28, 29].
Our results are of interest because this is the first study
demonstrating a change of BOLD response after successful
PTA. Its impact on clinical management in patient
treatment has to be investigated. However, further
investigations are warranted, including other techniques
like near infrared spectroscopy or nuclear magnetic
resonance spectroscopy to elucidate the underlying multi-
factorial mechanism in more detail.
In conclusion, BOLD-MRI reveals changes of the key
parameters T2*max, TTP, and EV after successful PTA of
the calf muscles during reactive hyperemia.
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